Interestingly, B220 downregulation is typical of B1 CD5+ B cells which are suspected to be the origin of leukemic cells in an Eμ-TLC1 mouse model of CLL [36]. The gene discussed is PTPRC; the disease is B-cell chronic lymphocytic leukemia.